Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Müller (2000)
Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: New facts and hypothesesGlia, 29
D. Cornblath, R. Hughes (1982)
Peripheral neuropathy.The New England journal of medicine, 307 23
J. Fortun, Jocelyn Go, Jie Li, S. Amici, W. Dunn, L. Notterpek (2006)
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpressionNeurobiology of Disease, 22
M. Bitoun, S. Maugenre, P. Jeannet, E. Lacène, X. Ferrer, P. Laforêt, Jean-Jacques Martin, J. Laporte, Hanns Lochmüller, A. Beggs, M. Fardeau, B. Eymard, N. Romero, P. Guicheney (2005)
Mutations in dynamin 2 cause dominant centronuclear myopathy.Nature genetics, 37 11
H. Azzedine, A. Bolino, T. Taïeb, N. Birouk, M. Duca, A. Bouhouche, S. Benamou, A. Mrabet, T. Hammadouche, T. Chkili, R. Gouider, R. Ravazzolo, A. Brice, J. Laporte, E. Leguern (2003)
Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.American journal of human genetics, 72 5
A. Bolino, A. Bolis, S. Previtali, G. Dina, S. Bussini, G. Dati, S. Amadio, U. Carro, D. Mruk, M. Feltri, C. Cheng, A. Quattrini, L. Wrabetz (2004)
Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesisThe Journal of Cell Biology, 167
G. Michailov, M. Sereda, Bastian Brinkmann, Tobias Fischer, Bernhard Haug, C. Birchmeier, L. Role, Cary Lai, M. Schwab, K. Nave (2004)
Axonal Neuregulin-1 Regulates Myelin Sheath ThicknessScience, 304
W. Dunn (1990)
Studies on the mechanisms of autophagy: formation of the autophagic vacuoleThe Journal of Cell Biology, 110
D. Rotin, O. Staub, R. Haguenauer‐Tsapis (2000)
Ubiquitination and Endocytosis of Plasma Membrane Proteins: Role of Nedd4/Rsp5p Family of Ubiquitin-Protein LigasesThe Journal of Membrane Biology, 176
K. Jessen, R. Mirsky (2005)
The origin and development of glial cells in peripheral nervesNature Reviews Neuroscience, 6
K. Roux, S. Amici, L. Notterpek (2004)
The temporospatial expression of peripheral myelin protein 22 at the developing blood‐nerve and blood‐brain barriersJournal of Comparative Neurology, 474
A. Jetten, Ueli Suteri (2000)
The peripheral myelin protein 22 and epithelial membrane protein family.Progress in nucleic acid research and molecular biology, 64
K. Szigeti, Carlos Garcia, J. Lupski (2006)
Charcot-Marie-Tooth disease and related hereditary polyneuropathies: Molecular diagnostics determine aspects of medical managementGenetics in Medicine, 8
A. Cuesta, L. Pedrola, T. Sevilla, J. García-Planells, M. Chumillas, F. Mayordomo, E. Leguern, I. Marín, J. Vílchez, F. Palau (2002)
The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A diseaseNature Genetics, 30
U. Suter, John MOSKOWt, A. Andrew, WELCHERt, G. Snipes, B. Kosaras, R. Sidman, Arthur BUCHBERGt, E. Shooter (1992)
A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse.Proceedings of the National Academy of Sciences of the United States of America, 89
P. Topilko, S. Schneider-Maunoury, G. Levi, A. Evercooren, Amina Chennoufi, T. Seitanidou, C. Babinet, P. Charnay (1994)
Krox-20 controls myelination in the peripheral nervous systemNature, 371
K. Giese, R. Martini, G. Lemke, Philippe Soriano, M. Schachner (1992)
Mouse P 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axonsCell, 71
S. Deschênes, Jessica Walcott, Tamara Wexler, S. Scherer, K. Fischbeck (1997)
Altered Trafficking of Mutant Connexin32The Journal of Neuroscience, 17
S. Züchner, J. Vance (2005)
Emerging pathways for hereditary axonopathiesJournal of Molecular Medicine, 83
Lilian Hagedorn, Ueli Suter, Lukas Sommer (1999)
P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors.Development, 126 17
M. Hanna, P. Cudia (2005)
Peripheral Nerve Diseases Associated with Mitochondrial Respiratory Chain Dysfunction
A. Jordanova, J. Irobi, F. Thomas, P. Dijck, K. Meerschaert, M. Dewil, I. Dierick, A. Jacobs, E. Vriendt, V. Guergueltcheva, Chitharanjan Rao, I. Tournev, F. Gondim, M. D’hooghe, V. Gerwen, P. Callaerts, L. Bosch, J. Timmermans, W. Robberecht, J. Gettemans, J. Thevelein, P. Jonghe, I. Kremensky, V. Timmerman (2006)
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathyNature Genetics, 38
U. Suter, AndrewA. Welcher, T. Özçelik, G. Snipes, B. Kosaras, U. Francke, S. Billings-Gagliardi, Richard Sidman, E. Shooter (1992)
Trembler mouse carries a point mutation in a myelin geneNature, 356
H. Takashima, C. Boerkoel, P. Jonghe, C. Ceuterick, Jean-Jacques Martin, T. Voit, J. Schröder, Anna Williams, P. Brophy, V. Timmerman, J. Lupski (2002)
Periaxin mutations cause a broad spectrum of demyelinating neuropathiesAnnals of Neurology, 51
F. Court, D. Sherman, T. Pratt, E. Garry, R. Ribchester, D. Cottrell, S. Fleetwood-Walker, P. Brophy (2004)
Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nervesNature, 431
C. Huxley, E. Passage, A. Manson, G. Putzu, D. Figarella-Branger, J. Pellissier, M. Fontès (1996)
Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA.Human molecular genetics, 5 5
D. Klein, Anthony Lee, D. Frank, M. Marks, M. Lemmon (1998)
The Pleckstrin Homology Domains of Dynamin Isoforms Require Oligomerization for High Affinity Phosphoinositide Binding*The Journal of Biological Chemistry, 273
S. Züchner, P. Jonghe, A. Jordanova, K. Claeys, V. Guergueltcheva, S. Cherninkova, S. Hamilton, G. Stavern, K. Krajewski, J. Stajich, I. Tournev, K. Verhoeven, C. Langerhorst, M. Visser, F. Baas, T. Bird, V. Timmerman, M. Shy, J. Vance (2006)
Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2Annals of Neurology, 59
Soo-A Kim, Panayiotis Vacratsis, R. Firestein, M. Cleary, J. Dixon (2003)
Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphataseProceedings of the National Academy of Sciences of the United States of America, 100
Javier Perea, A. Robertson, T. Tolmachova, J. Muddle, R. King, S. Ponsford, P. Thomas, C. Huxley (2001)
Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.Human molecular genetics, 10 10
A. Shirk, S. Anderson, Sayed Hashemi, P. Chance, C. Bennett (2005)
SIMPLE interacts with NEDD4 and TSG101: Evidence for a role in lysosomal sorting and implications for Charcot‐Marie‐Tooth diseaseJournal of Neuroscience Research, 82
S. Züchner, M. Noureddine, M. Kennerson, K. Verhoeven, K. Claeys, P. Jonghe, J. Merory, S. Oliveira, M. Speer, J. Stenger, G. Walizada, Danqing Zhu, M. Pericak-Vance, G. Nicholson, V. Timmerman, J. Vance (2005)
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth diseaseNature Genetics, 37
K. Adlkofer, R. Martini, A. Aguzzi, J. Zielasek, K. Toyka, U. Suter (1995)
Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient miceNature Genetics, 11
R. Martini (1999)
P0-deficient knockout mice as tools to understand pathomechanisms in Charcot-Marie-Tooth 1B and P0-related Déjérine-Sottas syndrome.Annals of the New York Academy of Sciences, 883
M. Sereda, G. Hörste, U. Suter, N. Uzma, K. Nave (2003)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)Nature Medicine, 9
S. Pareek, L. Notterpek, G. Snipes, R. Naef, W. Sossin, Jacynthe Laliberté, S. Iacampo, U. Suter, E. Shooter, R. Murphy (1997)
Neurons Promote the Translocation of Peripheral Myelin Protein 22 into MyelinThe Journal of Neuroscience, 17
Viren Konde, J. Eichberg (2006)
Myelin protein zero: Mutations in the cytoplasmic domain interfere with its cellular traffickingJournal of Neuroscience Research, 83
L. Warner, P. Mancias, I. Butler, C. McDonald, L. Keppen, K. Koob, J. Lupski (1998)
Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathiesNature Genetics, 18
K. Adlkofer, R. Naef, U. Suter (1997)
Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain‐of‐function alleleJournal of Neuroscience Research, 49
P. Chance, M. Alderson, K. Leppig, M. Lensch, N. Matsunami, Brooke Smith, P. Swanson, S. Odelberg, C. Disteche, T. Bird (1993)
DNA deletion associated with hereditary neuropathy with liability to pressure palsiesCell, 72
M. Sereda, I. Griffiths, Anja Pühlhofer, H. Stewart, M. Rossner, F. Zimmermann, J. Magyar, Armin Schneider, E. Hund, H. Meinck, U. Suter, K. Nave (1996)
A Transgenic Rat Model of Charcot-Marie-Tooth DiseaseNeuron, 16
F. Meggouh, M. Visser, W. Arts, R. Coo, I. Schaik, F. Baas (2005)
Early onset neuropathy in a compound form of Charcot–Marie–Tooth diseaseAnnals of Neurology, 57
S. Scherer, Yi-Tian Xu, A. Messing, K. Willecke, K. Fischbeck, L. Jeng (2005)
Transgenic Expression of Human Connexin32 in Myelinating Schwann Cells Prevents Demyelination in Connexin32-Null MiceThe Journal of Neuroscience, 25
A. Rünker, I. Kobsar, T. Fink, G. Loers, T. Tilling, Peggy Putthoff, C. Wessig, R. Martini, M. Schachner (2004)
Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorderThe Journal of Cell Biology, 165
A. Jeans, A. Isaacs, P. Oliver, L. Vizor, S. Brown, J. Hunter, K. Davies (2003)
Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy.Molecular and cellular neurosciences, 21 1
C. Jolliffe, K. Harvey, B. Haines, G. Parasivam, Sharad Kumar (2000)
Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4.The Biochemical journal, 351 Pt 3
S. LeBlanc, S. Jang, R. Ward, L. Wrabetz, J. Svaren (2006)
Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator*Journal of Biological Chemistry, 281
R. Martini, K. Toyka (2004)
Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patientsThe Lancet Neurology, 3
Xinghua Yin, G. Kidd, L. Wrabetz, M. Feltri, A. Messing, Bruce Trapp (2000)
Schwann Cell Myelination Requires Timely and Precise Targeting of P0 ProteinThe Journal of Cell Biology, 148
G. Saifi, K. Szigeti, W. Wiszniewski, M. Shy, K. Krajewski, I. Hausmanowa-Petrusewicz, A. Kochański, Suzanne Reeser, P. Mancias, I. Butler, J. Lupski (2005)
SIMPLE mutations in Charcot‐Marie‐Tooth disease and the potential role of its protein product in protein degradationHuman Mutation, 25
S. Carenini, D. Neuberg, M. Schachner, U. Suter, R. Martini (1999)
Localization and functional roles of PMP22 in peripheral nerves of P0‐deficient miceGlia, 28
Denarier Denarier, Forghani Forghani, Farhadi Farhadi, Dib Dib, Dionne Dionne, Friedman Friedman, Lepage Lepage, Hudson Hudson, Drouin Drouin, Peterson Peterson (2005)
Functional organization of a Schwann cell enhancerJ Neurosci, 25
K. Roux, S. Amici, B. Fletcher, L. Notterpek (2005)
Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22.Molecular biology of the cell, 16 3
R. Nagarajan, J. Svaren, N. Le, T. Araki, M. Watson, J. Milbrandt (2001)
EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene ExpressionNeuron, 30
M. Begley, J. Dixon (2005)
The structure and regulation of myotubularin phosphatases.Current opinion in structural biology, 15 6
A. Jordanova, F. Thomas, V. Guergueltcheva, I. Tournev, F. Gondim, B. Ishpekova, E. Vriendt, A. Jacobs, I. Litvinenko, N. Ivanova, Borjan Buzhov, P. Jonghe, I. Kremensky, V. Timmerman (2003)
Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.American journal of human genetics, 73 6
I. Shames, A. Fraser, J. Colby, W. Orfali, G., Jackson Snipes (2003)
Phenotypic Differences between Peripheral Myelin Protein‐22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot‐Marie‐Tooth‐Related DiseasesJNEN: Journal of Neuropathology & Experimental Neurology, 62
K. Sivakumar, T. Kyriakides, I. Puls, G. Nicholson, B. Funalot, A. Antonellis, N. Sambuughin, K. Christodoulou, J. Beggs, E. Zamba-Papanicolaou, V. Ionasescu, M. Dalakas, E. Green, K. Fischbeck, L. Goldfarb (2005)
Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.Brain : a journal of neurology, 128 Pt 10
Ning Liu, J. Yamauchi, E. Shooter (2004)
Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular traffickingNeurobiology of Disease, 17
S. Poliak, E. Peles (2003)
The local differentiation of myelinated axons at nodes of RanvierNature Reviews Neuroscience, 4
S. Bonneick, M. Boentert, P. Berger, S. Atanasoski, N. Mantei, C. Wessig, K. Toyka, P. Young, U. Suter (2005)
An animal model for Charcot-Marie-Tooth disease type 4B1.Human molecular genetics, 14 23
R. Avila, H. Inouye, R. Baek, Xinghua Yin, B. Trapp, M. Feltri, L. Wrabetz, D. Kirschner (2005)
Structure and Stability of Internodal Myelin in Mouse Models of Hereditary NeuropathyJournal of Neuropathology and Experimental Neurology, 64
H. Dang, Zhai Li, E. Skolnik, H. Fares (2003)
Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.Molecular biology of the cell, 15 1
S. Amici, W. Dunn, A. Murphy, N. Adams, N. Gale, D. Valenzuela, G. Yancopoulos, L. Notterpek (2006)
Peripheral Myelin Protein 22 Is in Complex with α6β4 Integrin, and Its Absence Alters the Schwann Cell Basal LaminaThe Journal of Neuroscience, 26
Hsiuchen Chen, D. Chan (2005)
Emerging functions of mammalian mitochondrial fusion and fission.Human molecular genetics, 14 Spec No. 2
P. Berger, S. Bonneick, S. Willi, M. Wymann, U. Suter (2002)
Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.Human molecular genetics, 11 13
L. Wrabetz, M. Feltri, A. Quattrini, D. Imperiale, S. Previtali, M. D’Antonio, R. Martini, Xinghua Yin, B. Trapp, Lei Zhou, S. Chiu, A. Messing (2000)
P0 Glycoprotein Overexpression Causes Congenital Hypomyelination of Peripheral NervesThe Journal of Cell Biology, 148
J. Fortun, W. Dunn, S. Joy, Jie Li, L. Notterpek (2003)
Emerging Role for Autophagy in the Removal of Aggresomes in Schwann CellsThe Journal of Neuroscience, 23
R. Balice-Gordon, L. Bone, S. Scherer (1998)
Functional Gap Junctions in the Schwann Cell Myelin SheathThe Journal of Cell Biology, 142
S. Scherer, Yi-Tian Xu, Eric Nelles, K. Fischbeck, K. Willecke, L. Bone (1998)
Connexin32‐null mice develop demyelinating peripheral neuropathyGlia, 24
S. Atanasoski, S. Scherer, Erich Sirkowski, Dino Leone, A. Garratt, C. Birchmeier, U. Suter (2006)
ErbB2 Signaling in Schwann Cells Is Mostly Dispensable for Maintenance of Myelinated Peripheral Nerves and Proliferation of Adult Schwann Cells after InjuryThe Journal of Neuroscience, 26
F. Saito, S. Moore, R. Barresi, M. Henry, A. Messing, S. Ross-Barta, R. Cohn, R. Williamson, K. Sluka, D. Sherman, P. Brophy, J. Schmelzer, P. Low, L. Wrabetz, M. Feltri, K. Campbell (2003)
Unique Role of Dystroglycan in Peripheral Nerve Myelination, Nodal Structure, and Sodium Channel StabilizationNeuron, 38
Alessandra Fontanini, R. Chies, E. Snapp, M. Ferrarini, G. Fabrizi, C. Brancolini (2005)
Glycan-independent Role of Calnexin in the Intracellular Retention of Charcot-Marie-Tooth 1A Gas3/PMP22 Mutants*Journal of Biological Chemistry, 280
E. Taillebourg, Stéphanie Buart, P. Charnay (2002)
Conditional, floxed allele of the Krox20 genegenesis, 32
Dino Leone, Sylvie Genoud, S. Atanasoski, R. Grausenburger, P. Berger, D. Metzger, W. Macklin, P. Chambon, U. Suter (2003)
Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cellsMolecular and Cellular Neuroscience, 22
M. Jaegle, M. Ghazvini, W. Mandemakers, M. Piirsoo, Siska Driegen, F. Levavasseur, Smiriti Raghoenath, F. Grosveld, D. Meijer (2003)
The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development.Genes & development, 17 11
H. Thompson, H. Cao, Jing Chen, U. Euteneuer, M. McNiven (2004)
Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion.Nature cell biology, 6 4
J. Ludes-Meyers, Hyunsuk Kil, A. Bednarek, J. Drake, M. Bedford, Claudio Aldaz (2004)
WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteinsOncogene, 23
A. Bolino, M. Muglia, F. Conforti, E. Leguern, M. Salih, D. Georgiou, K. Christodoulou, I. Hausmanowa-Petrusewicz, P. Mandich, A. Schenone, A. Gambardella, F. Bono, A. Quattrone, M. Devoto, A. Monaco (2000)
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2Nature Genetics, 25
P. Berger, Erich Sirkowski, S. Scherer, U. Suter (2004)
Expression analysis of the N-Myc downstream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-LomNeurobiology of Disease, 17
Andreas Tobler, L. Notterpek, R. Naef, V. Taylor, U. Suter, E. Shooter (1999)
Transport of Trembler-J Mutant Peripheral Myelin Protein 22 Is Blocked in the Intermediate Compartment and Affects the Transport of the Wild-Type Protein by Direct InteractionThe Journal of Neuroscience, 19
R. Naef, K. Adlkofer, B. Lescher, U. Suter (1997)
Aberrant Protein Trafficking inTremblerSuggests a Disease Mechanism for Hereditary Human Peripheral NeuropathiesMolecular and Cellular Neuroscience, 9
G. Lemke (2006)
Neuregulin-1 and MyelinationScience's STKE, 2006
Guya Giambonini-Brugnoli, J. Buchstaller, L. Sommer, U. Suter, N. Mantei (2005)
Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutationNeurobiology of Disease, 18
M. Ryan, E. Shooter, L. Notterpek (2002)
Aggresome Formation in Neuropathy Models Based on Peripheral Myelin Protein 22 MutationsNeurobiology of Disease, 10
S. Sancho, P. Young, U. Suter (2001)
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.Brain : a journal of neurology, 124 Pt 11
R. Gooding, J. Colomer, R. King, D. Angelicheva, L. Marns, Y. Parman, D. Chandler, J. Bertranpetit, L. Kalaydjieva (2005)
A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypesJournal of Medical Genetics, 42
Ken Inoue, K. Shilo, C. Boerkoel, C. Crowe, J. Sawady, J. Lupski, D. Agamanolis (2002)
Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: Phenotypes linked by SOX10 mutationAnnals of Neurology, 52
S. Niemann, M. Sereda, U. Suter, I. Griffiths, K. Nave (2000)
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22The Journal of Neuroscience, 20
M. Feltri, Diana Porta, S. Previtali, A. Nodari, B. Migliavacca, A. Cassetti, A. Littlewood-Evans, L. Reichardt, A. Messing, A. Quattrini, U. Mueller, L. Wrabetz (2002)
Conditional disruption of β1 integrin in Schwann cells impedes interactions with axonsThe Journal of Cell Biology, 156
D. Neuberg, S. Sancho, U. Suter (1999)
Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32Journal of Neuroscience Research, 58
Claudio Brancolini, Stefania Marzinotto, Paolo Edomi, Elena Agostoni, Carla Fiorentini, Hans Müller, Claudio Schneider (1999)
Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22.Molecular biology of the cell, 10 7
C. Meier, R. Dermietzel, K. Davidson, T. Yasumura, J. Rash (2004)
Connexin32-Containing Gap Junctions in Schwann Cells at the Internodal Zone of Partial Myelin Compaction and in Schmidt–Lanterman IncisuresThe Journal of Neuroscience, 24
A. Tobler, Ning Liu, L. Mueller, E. Shooter (2001)
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22Proceedings of the National Academy of Sciences of the United States of America, 99
Bao-sheng Chen, D. Nelson, Y. Sadovsky (2006)
N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury*Journal of Biological Chemistry, 281
H. Colognato, C. ffrench-Constant, M. Feltri (2005)
Human diseases reveal novel roles for neural lamininsTrends in Neurosciences, 28
S. Britsch, Derk Goerich, Derk Goerich, D. Riethmacher, R. Peirano, R. Peirano, M. Rossner, K. Nave, C. Birchmeier, M. Wegner, M. Wegner (2001)
The transcription factor Sox10 is a key regulator of peripheral glial development.Genes & development, 15 1
L. Notterpek, E. Shooter, G. Snipes (1997)
Upregulation of the Endosomal-Lysosomal Pathway in the Trembler-J NeuropathyThe Journal of Neuroscience, 17
L. Notterpek, K. Roux, S. Amici, Amy Yazdanpour, C. Rahner, Brad Fletcher (2001)
Peripheral myelin protein 22 is a constituent of intercellular junctions in epitheliaProceedings of the National Academy of Sciences of the United States of America, 98
C. Deangelis (2002)
Pain management: a call for papers.Archives of neurology, 59 12
S. LeBlanc, R. Srinivasan, C. Ferri, G. Mager, A. Gillian-Daniel, L. Wrabetz, J. Svaren (2005)
Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelinationJournal of Neurochemistry, 93
D. D'urso, R. Prior, R. Greiner-Petter, A. Gabreëls-Festen, H. Müller (1998)
Overloaded Endoplasmic Reticulum–Golgi Compartments, a Possible Pathomechanism of Peripheral Neuropathies Caused by Mutations of the Peripheral Myelin Protein PMP22The Journal of Neuroscience, 18
Jeffrey Huang, G. Phillips, A. Roth, L. Pedraza, W. Shan, W. Belkaid, S. Mi, Å. Fex-Svenningsen, L. Florens, J. Yates, D. Colman (2005)
Glial Membranes at the Node of Ranvier Prevent Neurite OutgrowthScience, 310
C. Gillespie, D. Sherman, S. Fleetwood-Walker, D. Cottrell, Steven Tait, E. Garry, V. Wallace, J. Ure, I. Griffiths, Austin Smith, P. Brophy (2000)
Peripheral Demyelination and Neuropathic Pain Behavior in Periaxin-Deficient MiceNeuron, 26
R. Hughes (2002)
Regular review: Peripheral neuropathyBMJ, 324
M. Feltri, L. Wrabetz (2005)
Laminins and their receptors in Schwann cells and hereditary neuropathiesJournal of the Peripheral Nervous System, 10
T. Sugiki, Y. Taketomi, R. Kikuchi‐Yanoshita, M. Murakami, I. Kudo (2004)
Association of N-myc downregulated gene 1 with heat-shock cognate protein 70 in mast cells.Biological & pharmaceutical bulletin, 27 5
Gerrit Praefcke, H. McMahon (2004)
The dynamin superfamily: universal membrane tubulation and fission molecules?Nature Reviews Molecular Cell Biology, 5
Yasuhiro Moriwaki, N. Begum, Mika Kobayashi, M. Matsumoto, K. Toyoshima, T. Seya (2001)
Mycobacterium bovis Bacillus Calmette-Guerin and Its Cell Wall Complex Induce a Novel Lysosomal Membrane Protein, SIMPLE, That Bridges the Missing Link between Lipopolysaccharide and p53-inducible Gene, LITAF(PIG7), and Estrogen-inducible Gene, EET-1 *The Journal of Biological Chemistry, 276
L. Pedrola, A. Espert, Xingyao Wu, R. Claramunt, M. Shy, F. Palau (2005)
GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.Human molecular genetics, 14 8
K. Inoue, K. Dewar, N. Katsanis, L. Reiter, E. Lander, K. Devon, D. Wyman, J. Lupski, B. Birren (2001)
The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.Genome research, 11 6
T. Okuda, Y. Higashi, K. Kokame, C. Tanaka, H. Kondoh, T. Miyata (2004)
Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral NervesMolecular and Cellular Biology, 24
N. Le, R. Nagarajan, James Wang, T. Araki, R. Schmidt, J. Milbrandt (2005)
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.Proceedings of the National Academy of Sciences of the United States of America, 102 7
C. Southwood, J. Garbern, Wei Jiang, A. Gow (2002)
The Unfolded Protein Response Modulates Disease Severity in Pelizaeus-Merzbacher DiseaseNeuron, 36
S. Previtali, B. Zerega, D. Sherman, P. Brophy, G. Dina, R. King, M. Salih, L. Feltri, A. Quattrini, R. Ravazzolo, L. Wrabetz, A. Monaco, A. Bolino (2003)
Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve.Human molecular genetics, 12 14
L. Shapiro, J. Doyle, P. Hensley, D. Colman, W. Hendrickson (1996)
Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve MyelinNeuron, 17
Esper Esper, Pankonin Pankonin, Loeb Loeb (2006)
Neuregulins: Versatile growth and differentiation factors in nervous system development and human diseaseBrain Res Brain Res Rev, 51
R. Naef, U. Suter (1999)
Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral NeuropathiesNeurobiology of Disease, 6
M. McNiven (2005)
Dynamin in diseaseNature Genetics, 37
H. Houlden, Mathilde Girard, Charles Cockerell, David Ingram, Nicholas Wood, Michel Goossens, Rodney Walker, Mary Reilly (2004)
Connexin 32 promoter P2 mutations: A mechanism of peripheral nerve dysfunctionClinical Neurophysiology, 118
E. Passage, J. Norreel, Pauline Noack-Fraissignes, V. Sanguedolce, J. Pizant, X. Thirion, A. Robaglia-Schlupp, J. Pellissier, M. Fontès (2004)
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth diseaseNature Medicine, 10
S. Pareek, U. Suter, G. Snipes, A. Welcher, E. Shooter, R. Murphy (1993)
Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells.The Journal of biological chemistry, 268 14
Giese Giese, Martini Martini, Lemke Lemke, Soriano Soriano, Schachner Schachner (1992)
Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axonsCell, 71
R. Martini, J. Zielasek, K. Toyka, K. Giese, M. Schachner (1995)
Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathiesNature Genetics, 11
M. Wegner, C. Stolt (2005)
From stem cells to neurons and glia: a Soxist's view of neural developmentTrends in Neurosciences, 28
J. Fortun, Jie Li, Jocelyn Go, A. Fenstermaker, B. Fletcher, L. Notterpek (2005)
Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy modelJournal of Neurochemistry, 92
J. Lupski, P. Chance (2005)
Chapter 70 – Hereditary Motor and Sensory Neuropathies Involving Altered Dosage or Mutation of PMP22: The CMT1A Duplication and HNPP Deletion
A. Antonellis, R. Ellsworth, N. Sambuughin, I. Puls, A. Abel, S. Lee-Lin, A. Jordanova, I. Kremensky, K. Christodoulou, L. Middleton, K. Sivakumar, V. Ionasescu, B. Funalot, J. Vance, L. Goldfarb, K. Fischbeck, E. Green (2003)
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.American journal of human genetics, 72 5
P. Jeannet, G. Bassez, B. Eymard, P. Laforêt, J. Urtizberea, A. Rouche, P. Guicheney, M. Fardeau, N. Romero (2004)
Clinical and histologic findings in autosomal centronuclear myopathyNeurology, 62
U. Suter, S. Scherer (2003)
Disease mechanisms in inherited neuropathiesNature Reviews Neuroscience, 4
M. Wishart, J. Dixon (2002)
PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.Trends in cell biology, 12 12
Raul Perez‐Olle, Sidonie Jones, R. Liem (2004)
Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.Human molecular genetics, 13 19
D. D'urso, Peter Ehrhardt, H. Müller (1999)
Peripheral Myelin Protein 22 and Protein Zero: a Novel Association in Peripheral Nervous System MyelinThe Journal of Neuroscience, 19
Marcel Maier, F. Castagner, P. Berger, U. Suter (2003)
Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neuronsMolecular and Cellular Neuroscience, 24
L. Notterpek, M. Ryan, A. Tobler, E. Shooter (1999)
PMP22 Accumulation in Aggresomes: Implications for CMT1A PathologyNeurobiology of Disease, 6
D. Fischer, M. Hérasse, M. Bitoun, H. Barragán-Campos, J. Chiras, P. Laforêt, M. Fardeau, B. Eymard, P. Guicheney, N. Romero (2006)
Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.Brain : a journal of neurology, 129 Pt 6
J. Senderek, C. Bergmann, S. Weber, U. Ketelsen, H. Schorle, S. Rudnik-Schöneborn, R. Büttner, E. Buchheim, K. Zerres (2003)
Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.Human molecular genetics, 12 3
P. Anzini, D. Neuberg, M. Schachner, Eric Nelles, K. Willecke, J. Zielasek, K. Toyka, U. Suter, R. Martini (1997)
Structural Abnormalities and Deficient Maintenance of Peripheral Nerve Myelin in Mice Lacking the Gap Junction Protein Connexin 32The Journal of Neuroscience, 17
K. Adlkofer, R. Frei, D. Neuberg, J. Zielasek, K. Toyka, U. Suter (1997)
Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous NeuropathyThe Journal of Neuroscience, 17
R. Chies, L. Nobbio, P. Edomi, A. Schenone, C. Schneider, C. Brancolini (2003)
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22Journal of Cell Science, 116
P. Berger, C. Schaffitzel, I. Berger, N. Ban, U. Suter (2003)
Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization moduleProceedings of the National Academy of Sciences of the United States of America, 100
S. Bouillot, M. Martin‐Négrier, Anne Vital, X. Ferrer, A. Lagueny, D. Vincent, M. Coquet, Orgogozo Jm, Bertrand Bloch, Claude Vital (2002)
Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literatureJournal of the Peripheral Nervous System, 7
J. Sáez, V. Berthoud, M. Brañes, Agustín Martínez, E. Beyer (2003)
Plasma membrane channels formed by connexins: their regulation and functions.Physiological reviews, 83 4
M. Shy (2006)
Peripheral neuropathies caused by mutations in the myelin protein zeroJournal of the Neurological Sciences, 242
Wishart Wishart, Dixon Dixon (2002)
PTEN and myotubularin phosphatases: From 3‐phosphoinositide dephosphorylation to disease. Phosphatase and tensin homolog deleted on chromosome tenTrends Cell Biol, 12
J. Edgar, J. Garbern (2004)
The myelinated axon is dependent on the myelinating cell for support and maintenance: Molecules involvedJournal of Neuroscience Research, 76
R. Peirano, Derk Goerich, D. Riethmacher, M. Wegner (2000)
Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10Molecular and Cellular Biology, 20
S. Previtali, A. Quattrini, M. Fasolini, M. Panzeri, A. Villa, M. Filbin, Wenhui Li, S. Chiu, A. Messing, L. Wrabetz, M. Feltri (2000)
Epitope-Tagged P0Glycoprotein Causes Charcot-Marie-Tooth–Like Neuropathy in Transgenic MiceThe Journal of Cell Biology, 151
C. Brancolini, P. Edomi, S. Marzinotto, C. Schneider (2000)
Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.Molecular biology of the cell, 11 9
L. Wrabetz, M. D’Antonio, M. Pennuto, G. Dati, E. Tinelli, P. Fratta, S. Previtali, D. Imperiale, J. Zielasek, K. Toyka, R. Avila, D. Kirschner, A. Messing, M. Feltri, A. Quattrini (2006)
Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic MiceThe Journal of Neuroscience, 26
J. Bergoffen, S. Scherer, Sumei Wang, MO Scott, L. Bone, D. Paul, K. Chen, M. Lensch, P. Chance, K. Fischbeck (1993)
Connexin mutations in X-linked Charcot-Marie-Tooth disease.Science, 262 5142
R. Lazzarini, K. Nave (2004)
Myelin Biology and Disorders
J. Senderek, C. Bergmann, C. Stendel, J. Kirfel, N. Verpoorten, P. Jonghe, V. Timmerman, R. Chrast, M. Verheijen, G. Lemke, E. Battaloğlu, Y. Parman, S. Erdem, E. Tan, H. Topaloğlu, A. Hahn, W. Müller-Felber, N. Rizzuto, G. Fabrizi, M. Stuhrmann, S. Rudnik-Schöneborn, S. Züchner, J. Schröder, E. Buchheim, V. Straub, J. Klepper, K. Huehne, B. Rautenstrauss, R. Büttner, E. Nelis, K. Zerres (2003)
Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy.American journal of human genetics, 73 5
C. Fabrizi, B. Kelly, C. Gillespie, W. Schlaepfer, S. Scherer, P. Brophy (1997)
Transient expression of the neurofilament proteins NF‐L and NF‐M by Schwann cells is regulated by axonal contactJournal of Neuroscience Research, 50
J Neurosci
C. Itallie, James Anderson (2006)
Claudins and epithelial paracellular transport.Annual review of physiology, 68
Sereda Sereda, Griffiths Griffiths, Puhlhofer Puhlhofer, Stewart Stewart, Rossner Rossner, Zimmermann Zimmermann, Magyar Magyar, Schneider Schneider, Hund Hund, Meinck Meinck, Suter Suter, Nave Nave (1996)
A rat transgenic model for Charcot‐Marie‐Tooth diseaseNeuron, 16
E. Nelis, S. Erdem, P. Bergh, M.-Cl Belpaire-Dethiou, C. Ceuterick, V. Gerwen, A. Cuesta, L. Pedrola, F. Palau, A. Gabreëls-Festen, C. Verellen, E. Tan, M. Demirci, C. Broeckhoven, P. Jonghe, H. Topaloğlu, V. Timmerman (2002)
Mutations in GDAP1: Autosomal recessive CMT with demyelination and axonopathyNeurology, 59
N. Joseph, Y. Mukouyama, J. Mosher, M. Jaegle, Steven Crone, E. Dormand, Kuo-Fen Lee, D. Meijer, D. Anderson, S. Morrison (2004)
Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells, 131
N. Le, R. Nagarajan, James Wang, J. Svaren, Christine LaPash, T. Araki, R. Schmidt, J. Milbrandt (2005)
Nab proteins are essential for peripheral nervous system myelinationNature Neuroscience, 8
U. Bartsch (2003)
Neural CAMS and their role in the development and organization of myelin sheaths.Frontiers in bioscience : a journal and virtual library, 8
Z. Sahenk, H. Nagaraja, B. McCracken, Wendy King, Miriam Freimer, J. Cedarbaum, J. Mendell (2005)
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patientsNeurology, 65
M. Shy, Á. Jáni, K. Krajewski, M. Grandis, R. Lewis, Jun Li, R. Shy, J. Balsamo, J. Lilien, J. Garbern, J. Kamholz (2004)
Phenotypic clustering in MPZ mutations.Brain : a journal of neurology, 127 Pt 2
N. Bondurand, Mathilde Girard, V. Pingault, Nicole Lemort, Odile Dubourg, Michel Goossens (2001)
Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.Human molecular genetics, 10 24
R. Michell, Victoria Heath, M. Lemmon, S. Dove (2006)
Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions.Trends in biochemical sciences, 31 1
J. Sanahuja, E. Franco, R. Rojas‐García, E. Gallardo, O. Combarros, R. Begué, P. Granes, I. Illa (2005)
Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association.Archives of neurology, 62 12
M. Khajavi, Ken Inoue, W. Wiszniewski, Tomoko Ohyama, G. Snipes, J. Lupski, J. Lupski (2005)
Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.American journal of human genetics, 77 5
J. Colby, R. Nicholson, K. Dickson, W. Orfali, R. Naef, U. Suter, G. Snipes (2000)
PMP22 Carrying the Trembler or Trembler-J Mutation Is Intracellularly Retained in Myelinating Schwann CellsNeurobiology of Disease, 7
L. Wrabetz, M. Feltri, K. Kleopa, S. Scherer (2004)
Inherited Neuropathies: Clinical, Genetic, and Biological Features
J. Ulzheimer, E. Peles, S. Levinson, R. Martini (2004)
Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutantsMolecular and Cellular Neuroscience, 25
D. Sherman, C. Fabrizi, C. Gillespie, P. Brophy (2001)
Specific Disruption of a Schwann Cell Dystrophin-Related Protein Complex in a Demyelinating NeuropathyNeuron, 30
J. Magyar, R. Martini, T. Ruelicke, A. Aguzzi, K. Adlkofer, Z. Dembić, J. Zielasek, K. Toyka, U. Suter (1996)
Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene DosageThe Journal of Neuroscience, 16
Axel Niemann, P. Berger, U. Suter (2007)
Pathomechanisms of mutant proteins in Charcot-Marie-Tooth diseaseNeuroMolecular Medicine, 8
M. Bicego, Sabina Morassutto, Victor Hernandez, M. Morgutti, F. Mammano, P. D'andrea, R. Bruzzone (2006)
Selective defects in channel permeability associated with Cx32 mutations causing X-linked Charcot–Marie–Tooth diseaseNeurobiology of Disease, 21
P. Berger, I. Berger, C. Schaffitzel, Kristian Tersar, B. Volkmer, U. Suter (2006)
Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2.Human molecular genetics, 15 4
A. Bolis, S. Coviello, S. Bussini, G. Dina, C. Pardini, S. Previtali, M. Malaguti, P. Morana, U. Carro, M. Feltri, A. Quattrini, L. Wrabetz, A. Bolino (2005)
Loss of Mtmr2 Phosphatase in Schwann Cells But Not in Motor Neurons Causes Charcot-Marie-Tooth Type 4B1 Neuropathy with Myelin OutfoldingsThe Journal of Neuroscience, 25
V. Timmerman, J. Lupski (2006)
The CMT1A Duplication and HNPP Deletion
C. Bennett, A. Shirk, H. Huynh, V. Street, E. Nelis, L. Maldergem, P. Jonghe, A. Jordanova, V. Guergueltcheva, I. Tournev, P. Bergh, P. Seeman, R. Mazanec, T. Procházka, I. Kremensky, J. Haberlova, M. Weiss, V. Timmerman, T. Bird, P. Chance (2004)
SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerveAnnals of Neurology, 55
Axel Niemann, M. Ruegg, Veronica Padula, A. Schenone, U. Suter (2005)
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial networkThe Journal of Cell Biology, 170
Michael Hunter, D. Angelicheva, I. Tournev, E. Ingley, D. Chan, G. Watts, I. Kremensky, L. Kalaydjieva (2005)
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.Biochemical and biophysical research communications, 332 4
J. Ghislain, P. Charnay (2006)
Control of myelination in Schwann cells: a Krox20 cis‐regulatory element integrates Oct6, Brn2 and Sox10 activitiesEMBO reports, 7
D. Sherman, P. Brophy (2005)
Mechanisms of axon ensheathment and myelin growthNature Reviews Neuroscience, 6
M. Clague, O. Lorenzo (2005)
The Myotubularin Family of Lipid PhosphatasesTraffic, 6
Michael Hunter, R. Bernard, Elizabeth Freitas, A. Boyer, B. Morar, I. Martins, I. Tournev, A. Jordanova, Velina Guergelcheva, Boryana Ishpekova, I. Kremensky, G. Nicholson, B. Schlotter, Hanns Lochmüller, T. Voit, J. Colomer, P. Thomas, N. Lévy, L. Kalaydjieva (2003)
Mutation screening of the N‐myc downstream‐regulated gene 1 (NDRG1) in patients with Charcot‐Marie‐Tooth DiseaseHuman Mutation, 22
Fred Robinson, J. Dixon (2005)
The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease*Journal of Biological Chemistry, 280
Niemann Niemann, Ruegg Ruegg, La Padula La Padula, Schenone Schenone, Suter Suter (2005)
Ganglioside‐induced differentiation associated protein 1 is a regulator of the mitochondrial network: New implications for Charcot‐Marie‐Tooth diseaseJ Cell Biol, 170
B. Hasse, F. Bosse, H. Hanenberg, H. Müller (2004)
Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactionsMolecular and Cellular Neuroscience, 27
D. Parkinson, A. Bhaskaran, Anna Droggiti, S. Dickinson, M. D’Antonio, R. Mirsky, K. Jessen (2004)
Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and deathThe Journal of Cell Biology, 164
R. Esper, Mark Pankonin, J. Loeb (2006)
Neuregulins: Versatile growth and differentiation factors in nervous system development and human diseaseBrain Research Reviews, 51
U. Suter, G. Snipes (1995)
Biology and genetics of hereditary motor and sensory neuropathies.Annual review of neuroscience, 18
J. Laporte, Florence Bedez, A. Bolino, J. Mandel (2003)
Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.Human molecular genetics, 12 Spec No 2
E. Fabbretti, P. Edomi, C. Brancolini, C. Schneider (1995)
Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.Genes & development, 9 15
G. Snipes, U. Suter, AndrewA. Welcher, E. Shooter (1992)
Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13)The Journal of Cell Biology, 117
C. Taveggia, G. Zanazzi, Ashley Petrylak, H. Yano, J. Rosenbluth, S. Einheber, Xiaorong Xu, R. Esper, J. Loeb, P. Shrager, M. Chao, D. Falls, L. Role, J. Salzer (2005)
Neuregulin-1 Type III Determines the Ensheathment Fate of AxonsNeuron, 47
R. Baxter, K. Othmane, J. Rochelle, J. Stajich, C. Hulette, S. Dew-Knight, F. Hentati, M. Hamida, S. Bel, J. Stenger, J. Gilbert, M. Pericak-Vance, J. Vance (2002)
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21Nature Genetics, 30
Keith Dickson, J. Bergeron, Iman Shames, J. Colby, D. Nguyen, É. Chevet, David Thomas, G. Snipes (2002)
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for “gain-of-function” ER diseasesProceedings of the National Academy of Sciences of the United States of America, 99
Houlden Houlden, Girard Girard, Cockerell Cockerell, Ingram Ingram, Wood Wood, Goossens Goossens, Walker Walker, Reilly Reilly (2004)
Connexin 32 promoter P2 mutations: A mechanism of peripheral nerve dysfunctionAnn Neurol, 56
Over the last 15 years, a number of mutations in a variety of genes have been identified that lead to inherited motor and sensory neuropathies (HMSN), also called Charcot‐Marie‐Tooth disease (CMT). In this review we will focus on the molecular and cellular mechanisms that cause the Schwann cell pathologies observed in dysmyelinating and demyelinating forms of CMT. In most instances, the underlying gene defects alter primarily myelinating Schwann cells followed by secondary axonal degeneration. The first set of proteins affected by disease‐causing mutations includes the myelin components PMP22, P0/MPZ, Cx32/GJB1, and periaxin. A second group contains the regulators of myelin gene transcription EGR2/Krox20 and SOX10. A third group is composed of intracellular Schwann cells proteins that are likely to be involved in the synthesis, transport and degradation of myelin components. These include the myotubularin‐related lipid phosphatase MTMR2 and its regulatory binding partner MTMR13/SBF2, SIMPLE, and potentially also dynamin 2. Mutations affecting the mitochondrial fission factor GDAP1 may indicate an important contribution of mitochondria in myelination or myelin maintenance, whereas the functions of other identified genes, including NDRG1, KIAA1985, and the tyrosyl‐tRNA synthase YARS, are not yet clear. Mutations in GDAP1, YARS, and the pleckstrin homology domain of dynamin 2 lead to an intermediate form of CMT that is characterized by moderately reduced nerve conduction velocity consistent with minor myelin deficits. Whether these phenotypes originate in Schwann cells or in neurons, or whether both cell types are directly affected, remains a challenging question. However, based on the advances in systematic gene identification in CMT and the analyses of the function and dysfunction of the affected proteins, crucially interconnected pathways in Schwann cells in health and disease have started to emerge. These networks include the control of myelin formation and stability, membrane trafficking, intracellular protein sorting and quality control, and may extend to mitochondrial dynamics and basic protein biosynthesis. © 2006 Wiley‐Liss, Inc.
Glia – Wiley
Published: Sep 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.